ASGR1 and coronary artery disorder: In 2016, Nioi et al. (12) reported that two human ASGR1-deletion variants found in Iceland, resulting in truncated proteins, likely inactive, are associated with a modest ∼10% to 14% reduction in LDLc, yet with a significant ∼34% reduced risk of coronary artery disease.